KRAS and colorectal carcinoma: In patients with metastasized colorectal cancer (CRC), cfDNA testing for Kirsten rat sarcoma viral oncogene homolog (KRAS) and neuroblastoma rat sarcoma viral oncogene homolog (NRAS) mutations also holds prognostic value [12].